Iron-(Fe3+) dependent reactivation of telomerase drives colorectal cancers.
Raghuvaran ShanmugamPrativa MajeeWei ShiMert Burak OzturkThamil Selvan VaiyapuriKhaireen IdzhamAnandhkumar RajuSeung Hee ShinKerem FidanJoo-Leng LowJoelle Yi Heng ChuaYap Choon KongOng Yue QiEmile John Kwong Wei TanAik Yong ChokIsaac Seow-EnIan Jun Yan WeeDominique Camat MacalinaoDawn Qingqing ChongHong Yun ChangYi Xin Fiona LeeWei Qiang LeowMaki Murata-HoriZhang XiaoqianChia ShumeiChris Soon Heng TanRamanuj DasGuptaIain Beehuat TanVinay TergaonkarPublished in: Cancer discovery (2024)
Over-consumption of iron-rich red meat and hereditary or genetic iron overload are associated with increased risk of colorectal carcinogenesis, yet the mechanistic basis of how metal-mediated signaling leads to oncogenesis remains enigmatic. Using fresh colorectal cancer (CRC) samples we identify Pirin, an iron sensor, that overcomes a rate-limiting step in oncogenesis, by re-activating the dormant human-reverse-transcriptase (hTERT) subunit of telomerase holoenzyme in an iron-(Fe3+)-dependent-manner and thereby drives CRCs. Chemical genetic screens combined with isothermal-dose response fingerprinting and mass-spectrometry identified a small molecule SP2509, that specifically inhibits Pirin-mediated hTERT reactivation in CRCs by competing with iron-(Fe3+) binding. Our findings, first to document how metal ions reactivate telomerase, provide a molecular mechanism for the well-known association between red meat, and increased incidence of CRCs. Small molecules like SP2509 represent a novel modality to target telomerase that acts as driver of 90% human cancers and is yet to be targeted in clinic.